MedTrace Logo

Cellular and Tissue Based Therapy Registry

NCT02322554 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2018-05-01

No results posted yet for this study

Summary

The goal of the Cellular and Tissue Based Therapy Registry (CTPR) for Wounds is to provide real world patient data from electronic health records submitted to meet Stage 2 Meaningful Use in order to understand the value of these products among patients with chronic wounds and ulcers. Randomized, controlled trials to establish product efficacy routinely exclude patients with the co-morbid conditions common to patients seen in usual clinical practice and thus the results of these RCTs tend to be non-generalizable. Little is known about the effectiveness of CTPs among typical patients.

Conditions

  • Diabetic Foot Ulcers
  • Venous Stasis Ulcer
  • Pressure Ulcer
  • Chronic Non Healing Wound
  • Surgical Wound Dehiscence

Interventions

BIOLOGICAL

Cellular and tissue based products

Procedure: Application of device or biological to wounds

Sponsors & Collaborators

  • U.S. Wound Registry

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322554 on ClinicalTrials.gov